Cargando…

Optimal Medications and Appropriate Implantable Cardioverter-defibrillator Shocks in Aborted Sudden Cardiac Death Due to Coronary Spasm

OBJECTIVE: Life-threatening ventricular arrhythmias are recognized in patients with coronary spastic angina. Implantable cardioverter-defibrillators (ICDs) are effective in patients with structural heart disease and ventricular fibrillation. However, the optimal medication for patients with aborted...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sueda, Shozo, Kohno, Hiroaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995710/ https://www.ncbi.nlm.nih.gov/pubmed/29321418 http://dx.doi.org/10.2169/internalmedicine.8796-17

Ejemplares similares

Sequential Spasm Provocation Tests under Medications Are Indispensable in Patients with Aborted Sudden Cardiac Death due to Coronary Spasm
por: Sueda, Shozo, et al.
Publicado: (2020)

Spasm Provocation Tests under Medication May Help Decide on Medical or Mechanical Therapy in Patients with Aborted Sudden Cardiac Death due to Coronary Spasm
por: Sueda, Shozo, et al.
Publicado: (2020)

Cardiogenic Shock due to Pulseless Electrical Activity Arrest Associated with Severe Coronary Artery Spasm
por: Sueda, Shozo, et al.
Publicado: (2018)

Subcutaneous Implantable Cardioverter-Defibrillator Shock: Appropriate or Inappropriate?
por: Ip, James E.
Publicado: (2017)

Predictors of appropriate therapy in patients with implantable cardioverter-defibrillator for primary prevention of sudden cardiac death
por: Ahmed, Imdad, et al.
Publicado: (2010)

Subcutaneous implantable cardioverter-defibrillator was inappropriate for use in a patient with aborted sudden cardiac death due to coronary spastic angina: a case report
por: Kojima, Akiteru, et al.
Publicado: (2020)

An appropriate shock of the wearable cardioverter-defibrillator in an outpatient setting
por: Kishihara, Jun, et al.
Publicado: (2016)

Appropriate Implantable Cardioverter-Defibrillator Therapy in Patients with Ventricular Arrhythmia of Unclear Cause in Secondary Prevention of Sudden Cardiac Death
por: Noordman, Alwin B. P., et al.
Publicado: (2023)

Subcutaneous implantable cardioverter-defibrillator (S-ICD) for secondary prevention of sudden cardiac death
por: Kempa, Maciej, et al.
Publicado: (2016)

Implantable Cardioverter‐Defibrillators for Secondary Prevention of Sudden Cardiac Death: A Review
por: Borne, Ryan T., et al.
Publicado: (2017)

Use of Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death in Asia
por: Ueda, Nobuhiko, et al.
Publicado: (2023)

Catheter-induced Spasm in the Proximal Right Coronary Artery
por: Sueda, Shozo, et al.
Publicado: (2018)

Implantable cardioverter-defibrillator prevents sudden death in patients with Chagas cardiomyopathy in the Brazilian Amazon
por: Couceiro, Katia do Nascimento, et al.
Publicado: (2021)

Sudden Cardiac Death Risk over Time in HCM Patients with Implantable Cardioverter-Defibrillator
por: Klopotowski, Mariusz, et al.
Publicado: (2022)

Incidence of appropriate cardioverter-defibrillator shocks and mortality in patients with implantable cardioverter-defibrillators with ischemic cardiomyopathy versus nonischemic cardiomyopathy at 33-month follow-up
por: Gandhi, Kaushang, et al.
Publicado: (2010)

Impact of Moderate to Severe Renal Impairment on Mortality and Appropriate Shocks in Patients with Implantable Cardioverter Defibrillators
por: Alla, Venkata M., et al.
Publicado: (2010)

Predictors of appropriate ICD therapy in patients with implantable cardioverter-defibrillator
por: Dehghani, Mohammad Reza, et al.
Publicado: (2006)

Subcutaneous implantable cardioverter-defibrillator implantation for ventricular fibrillation caused by coronary artery spasm: a case report
por: Ito, Naruhiko, et al.
Publicado: (2018)

Ventricular tachycardia prediction in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death
por: Lebedeva, Viktoria K., et al.
Publicado: (2018)

Subcutaneous Implantable Cardioverter Defibrillators for the Prevention of Sudden Cardiac Death: Pediatric Single-Center Experience
por: Wieniawski, Piotr, et al.
Publicado: (2022)

Updated risk assessments for sudden cardiac death in hypertrophic cardiomyopathy patients with implantable cardioverter-defibrillator
por: Park, Yae Min
Publicado: (2023)

Association of Night-Time Heart Rate With Ventricular Tachyarrhythmias, Appropriate and Inappropriate Implantable Cardioverter-Defibrillator Shocks
por: Sun, Xuerong, et al.
Publicado: (2021)

Management of implantable cardioverter-defibrillator patients with appropriate ICD shocks: A 3-step treatment concept
por: Kleemann, Thomas, et al.
Publicado: (2021)

An “UninTENSional” Subcutaneous Implantable Cardioverter-defibrillator Shock
por: Turner, Suzette L., et al.
Publicado: (2018)

Inappropriate subcutaneous implantable cardioverter-defibrillator shocks for bradycardia
por: Chua, Kelvin C.M., et al.
Publicado: (2021)

Underutilization of Implantable Cardioverter Defibrillator in Primary Prevention of Sudden Cardiac Arrest
por: Lakshmanadoss, Umashankar, et al.
Publicado: (2011)

Fragmented QRS as a Predictor of Appropriate Implantable Cardioverter-defibrillator Therapy
por: Apiyasawat, Sirin, et al.
Publicado: (2014)

Baseline and Dynamic Risk Predictors of Appropriate Implantable Cardioverter Defibrillator Therapy
por: Wu, Katherine C., et al.
Publicado: (2020)

Strategies to Reduce Recurrent Shocks Due to Ventricular Arrhythmias in Patients with an Implanted Cardioverter-Defibrillator
por: Back, Steven H, et al.
Publicado: (2019)

Comparison of Inappropriate Shocks and Other Health Outcomes Between Single‐ and Dual‐Chamber Implantable Cardioverter‐Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter‐Defibrillators
por: Peterson, Pamela N., et al.
Publicado: (2017)

Improving the appropriateness of sudden arrhythmic death primary prevention by implantable cardioverter-defibrillator therapy in patients with low left ventricular ejection fraction. Point of view
por: Disertori, Marcello, et al.
Publicado: (2016)

Implantable cardioverter-defibrillators /
Publicado: (1994)

Effects and Complications of Subcutaneous Implantable Cardioverter-Defibrillator in the Prevention of Sudden Cardiac Death: A Narrative Review
por: Pagore, Prasad A, et al.
Publicado: (2022)

Sex difference in appropriate shocks but not mortality during long-term follow-up in patients with implantable cardioverter-defibrillators
por: Seegers, Joachim, et al.
Publicado: (2016)

Inappropriate implantable cardioverter defibrillator shocks—incidence, effect, and implications for driver licensing
por: Watanabe, Eiichi, et al.
Publicado: (2017)

The Value of the Tei Index in Predicting Implantable Cardioverter Defibrillator Shocks
por: Seyis, Sabri
Publicado: (2018)

Optimal Strategies to Reduce Inappropriate Implantable Cardioverter-defibrillator Shocks
por: Fleeman, Blake E., et al.
Publicado: (2019)

Implantable Cardioverter‐Defibrillator Shocks During COVID‐19 Outbreak
por: Adabag, Selçuk, et al.
Publicado: (2021)

Implantable cardioverter-defibrillator shocks and nonsustained rapid ventricular rhythms
por: Witteveen, H., et al.
Publicado: (2022)

Implantable cardioverter-defibrillator shocks and nonsustained rapid ventricular rhythms
por: Witteveen, H., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j57fspd21n820f5t3png1tkege